Abstract Cirrhosis of the liver is associated with increased fucosylation of proteins in the plasma. We describe a dataindependent (DIA) strategy for comparative analysis of the site-specific glycoforms of plasma glycoproteins. A library of 161 glycoforms of 25 N-glycopeptides was established by data-dependent LC-MS/MS analysis of a tryptic digest of 14 human protein groups retained on a multiple affinity removal column. The collision-induced dissociation conditions were adjusted to maximize the yield of selective Y-ions which were quantified by a data-independent mass spectrometry workflow using a 10-Da acquisition window. Using this workflow, we quantified 125 glycoforms of 25 glycopeptides, covering 10 of the 14 proteins, without any further glycopeptide enrichment. Comparison of the proteins in the plasma of healthy controls and cirrhotic patients shows an average 1.5-fold increase in the fucosylation of bi-antennary glycoforms and 3-fold increase in the fucosylation of tri-and tetraantennary glycoforms. These results show that the adjusted glycopeptide DIA workflow using soft collision-induced fragmentation of glycopeptides is suitable for site-specific analysis of protein glycosylation in complex mixtures of analytes without glycopeptide enrichment.
Introduction
Glycosylation of proteins is an integral part of life where diverse classes of glycans carry out distinct functions [1, 2] . Heterogeneity of this common modification makes its analysis challenging [3] [4] [5] . Recent innovations facilitate glycoproteomic research [6, 7] but, in spite of these advances, properties of glycopeptides complicate detection and quantification by MS [8, 9] . Glycoproteomic studies frequently benefit from independent analysis of detached glycans because full structural characterization of glycans is difficult to complete on glycopeptides [10] [11] [12] . Similarly, proteomic analyses are complicated by the attached glycans and most studies of glycoproteins are carried out after de-glycosylation [13] [14] [15] . We need to study site-specific glycoforms and quantify their changes in the context of diseases to understand the structurefunction relationships that tie glycoproteins to pathophysiological processes [16] [17] [18] [19] . However, methods for quantitative comparisons of site-specific protein glycoforms have only begun to emerge [9] . While the comparative analysis of proteins by data-independent acquisition (DIA) has improved the efficiency of quantitative proteomics analyses [20, 21] , applications of DIA methods to the analysis of posttranslational modifications are limited and virtually non-existent for glycoproteins [22] . In this paper, we introduce a workflow for DIA analysis of N-glycopeptides under soft CID fragmentation conditions and document applicability of the glycopeptide DIA (Glycopeptide SWATH or GP-SWATH) workflow to the comparative analysis of fucosylated complex glycoforms of 10 abundant plasma glycoprotein groups in the context of liver cirrhosis.
Patients, materials, and methods

Study population
Data-dependent analysis of the N-glycosylation of major serum glycoproteins was carried out using pooled samples of cirrhotic patients and healthy individuals enrolled in collaboration with the Department of Hepatology and Liver Transplantation, Georgetown University Hospital, Washington, DC, under protocols approved by the Institutional Review Board as described previously [23] . All of the cirrhotic patients had chronic hepatitis C viral infection as the primary diagnosis. Blood samples were collected using EDTA Vacutainer tubes (BD Diagnostics, Franklin Lakes, NJ). Plasma was collected according to the manufacturer's protocol within 6 h of the blood draw and was stored at −80°C until use. Comparative quantification of the Nglycopeptides by the GP-SWATH DIA workflow was carried out on paired pools of samples (equal volume of plasma of five participants per pool) from the same patient population. Participants were split into groups of five and plasma samples for each group were pooled for analysis (two pools per group, five participants per pool); each pool was analyzed in triplicate to document reproducibility of the workflow. All of the groups were matched on age, race (60 % Caucasian, 40 % AfricanAmerican), and gender (80 % males); HCC and cirrhosis groups were further matched on MELD score as described in [23] .
MARS 14 affinity chromatography of plasma samples and sample preparation
Affinity chromatography was carried out on HP 1100 HPLC system (Agilent, Santa Clara, CA) and Multiple Affinity Removal Column Human 14 (MARS 14, Agilent). Chromatography conditions were set according to manufacturer's protocol. Briefly, human plasma (20 μl) was mixed with buffer A (85 μl) and injected on the column. Affinity buffers A and B were used as mobile phases, 100 % A at a flow rate 0.25 ml/min at 0-9 min, 100 % B at a flow rate 1 ml/ min at 9-15 min, and 100 % A at a flow rate 1 ml/min at 15-20 min. The peak of the retained fraction was manually collected. Amicon microspin column with 3000-Da cut-off and 0.5 ml volume was used to concentrate 1/4 of the retained fraction (cca 320 μg of protein) and to exchange Agilent buffer B to 50 mM ammonium bicarbonate. Rapigest (Waters, Milford, MA) was added to a final concentration of 0.05 % and incubated with the proteins at 37°C for 1 h. Samples were reduced with 5 mM DTT, alkylated with 15 mM IAA, residual IAA was quenched with 5 mM DTT, and the samples were digested overnight using trypsin Gold (Promega, V5280) in a ratio 1/20 to the total protein.
Endoglycosidase and exoglycosidase treatment of the N-glycopeptides
Tryptic digests (50 μg) were de-sialylated with neuraminidase (New England BioLabs, Ipswich, MA) at 37°C using pressurized accelerated digestion (barocycler) technology (Pressure Biosciences, South Easton, MA). Completion of the de-sialylation reaction was confirmed by LC-MS/MS analysis. De-sialylated glycopeptides were evaporated in a vacuum concentrator (Labconco, Kansas City, MO) and dissolved in mobile phase A (2 % ACN, 0.1 % FA) for LC-MS/MS measurements. For the analysis of site occupancy, aliquots of the tryptic digests (50 μg) were heated at 99°C for 10 min to deactivate trypsin. Five microliters of de-glycosylation buffer G7 (New England BioLabs, Ipswich, MA) was added to 50 μg of each tryptic digest and the samples were evaporated in a vacuum concentrator (Labconco) and dissolved in 50 μl of 18 O water for de-glycosylation with 0.5 μl PNGase F (New England BioLabs) using a 1-h barocycler-assisted protocol as described previously [24] .
Study of glycopeptide fragmentation and identification of glycopeptides by LC-MS/MS
Tryptic digest of glycoprotein standards with and without neuraminidase treatment (Hemopexin, Haptoglobin, SHBG) was measured by data-dependent acquisition (DDA) and parallel reaction monitoring (PRM) LC-MS/ MS analysis. Glycopeptide separation was achieved by a 45-min gradient using the MS/MS conditions described below. Collision energy was altered between conditions optimal for the analysis of peptides and low energy CID used to determine the Y-ions optimal for detection of the glycopeptides. The optimized CID conditions (soft fragmentation) were used for further analysis of glycopeptides in the MARS 14 fractions. Glycopeptide separation was achieved on a Nanoacquity LC (Waters, Milford, MA) using capillary trap, 180 μm × 0.5 mm, and analytical 75 μm × 150 mm Atlantis DB C18, 3 μm, 300 Å columns . A 4-min trapping step using 2 % ACN, 0.1 % formic acid at 15 μl/min was followed by chromatographic separation at 0.4 μl/min as follows: starting conditions were 5 % ACN, 0.1 % formic acid; 1-35 min, 5-50 % ACN, 0.1 % formic acid; 35-37 min, 50-95 % ACN, 0.1 % formic acid; 37-40 min, 95 % ACN, 0.1 % formic acid followed by equilibration to starting conditions for additional 20 min. For all of the runs, we injected 0.5 μl (0.5 μg of human plasma proteins derived from 14.3 nl of plasma) of tryptic digest directly onto the column. We have used a DDA workflow with one MS1 full scan (400-1800 m/z) and three MS/MS fragmentations (100-1800). MS/MS spectra were recorded in the range 400-2000 m/z with resolution 30,000 and mass accuracy less than 15 ppm using the following experimental parameters: declustering potential 80 V, curtain gas 30, ion spray voltage 2300 V, ion source gas1 11, interface heater 150°C, entrance potential 10 V, collision exit potential 11 V. Glycopeptide identities were assigned manually. Four parameters were used for positive glycopeptide identification (retention time, HR precursor mass, charge state, and MS/MS spectra). Identified glycopeptides were quantified using peak area of the extracted ion chromatograms (XIC) of the product (Y) ions. Peak integration was performed manually using MultiQuant 2.0 software (Sciex) using a full cluster method (window width of 1.2 Da).
DIA analysis of the glycopeptides
Samples were prepared as described above and measured under optimized conditions using rolling CE (CE 3+ = 0.03 × M −5 ) and a 10-Da SWATH window step. Tryptic digests of the MARS 14 fraction were separated using a 90-min gradient elution as described above. Y-ion isotope cluster chromatograms, based on an isolation window of 1.2 Da, were extracted from the SWATH MS/MS and used for analysis of the glycopeptide intensities. We have used a maximum of 1.0 min RT difference from the RT of the major glycoform as a qualitative parameter for positive identification of the glycoforms. Areas of the fucosylated glycopeptides were normalized to the areas of corresponding non-fucosylated analytes for the analysis of the degree (%) of fucosylation. All of the quantifiable glycoform ratios (see Electronic Supplementary Material (ESM) Table S1 ) were averaged across the bi-and tri/ tetra-antennary glycoforms to derive summary changes between healthy controls and liver cirrhosis patient groups. The total areas of all tri/tetra-antennary glycopeptides were normalized to the total areas of bi-antennary glycopeptides for the analysis of branching.
Results and discussion
Fragmentation of glycopeptides under soft CID conditions
Glycoprotein standards were measured using data-dependent (DDA) and scheduled (PRM) MS/MS methods in order to optimize the fragmentation of glycopeptides and maximize the yield of informative Y-ions. Lower energy, corresponding to approximately 50 % collision energy optimal for the fragmentation of peptides, was found sufficient for an efficient fragmentation of the complex N-glycopeptides. Characteristic Y-ions, corresponding to the loss of one Nglycan arm due to the weak Man-GlcNAc glycosidic bond, were identified as the major fragmentation pathway (Fig. 1) . This characteristic loss is reproducible across all of the structures of the complex glycans examined (Fig. 1A) as well as across various peptide backbones ( Fig. 1B; ESM Fig. S1 ). Peptide fragmentation is minimized (virtually eliminated) by the soft fragmentation conditions, which means that interference from peptides in the MS/MS spectra of samples with complex background are minimized as well ( ESM Fig. S2 ); this contributes to the high selectivity of the Y-ions and high overall specificity of complex N-glycopeptide detection by the GP-SWATH workflow. Specificity of the Y-ions is substantially higher than the specificity of the corresponding Bions which may have higher intensity at higher collision energies but cannot achieve specific glycopeptide detection in complex samples. Sensitivity of the quantification of the Yions is by definition higher than quantification of the precursor ions. We want to point out that we do not propose relative quantification of the distribution of glycoforms in each sample by the soft fragmentation GP-SWATH workflow; we propose comparative quantification of specific glycoforms between samples as documented below on the analysis of fucosylated glycoforms in cirrhotic patients and healthy controls.
Construction of a glycopeptide library
Tryptic digest of the MARS 14 retentate treated with neuraminidase was analyzed by DDA LC-MS/MS to construct a library of glycopeptides and their glycoforms. Retention characteristics under reversed phase chromatographic conditions and fragmentation characteristics under soft CID conditions were determined for the major glycoform of 18 glycopeptides derived from 10 glycoprotein groups retained on the MARS 14 column (Table 1) . We selected the MARS 14 retentate because the majority of the glycoproteins and their glycoforms were previously examined by us and others [25, 26] which serves as a reference for evaluation of this novel workflow.
As we discussed, the fragmentation of the complex Nglycopeptides is quite consistent and predictable. The Y-ions selected for quantification have high mass and predictable charge (typically one z less than the precursor) which increases reliability of their quantification. In addition, retention time alignment can be used as an important qualitative parameter for evaluation of the glycoforms of each glycopeptide as each additional neutral oligosaccharide decreases the retention time by a small amount under the reversed phase condition [27] . Influence of the glycan structures on the retention time is predictable and we expect that formal models of retention behavior will be used in the future for automated data interpretation. We used a 1-min retention window around the major glycoform as a criterion for identification of the peak as a related glycoform of the same peptide. For example, six glycoforms (2A, 2AF, 3A, 3AF, 4A, 4AF) of the VVLHPNYSQVDIGLIK tryptic peptide of haptoglobin align in retention time between 32.65 and 33.07 min (Fig. 2) which further strengthens our confidence in the assignments. This figure also documents high selectivity of the Y-ions as seen with the minimal signal besides the peaks of the analytes of interest detected at the expected retention times.
We also carried out confirmatory analysis using PNGaseF de-glycosylation in the presence of 18 O water as described previously [25] in order to verify the correct assignments of the glycopeptides by LC-MS/MS and to examine retention Table S1 ); all of the results were manually verified and 125 of these glycoforms were quantifiable in all of the samples examined. Comparative DIA quantification of these glycoforms in paired pools of plasma of the cirrhotic patients and healthy controls was examined in triplicate and summarized below. Our results suggest that the fragmentation and retention behavior of the glycopeptides is consistent enough to allow future expansion of the library to additional glycoforms and peptides that were not examined a priori by DDA analysis. At this point, we want to minimize false positive identifications and limit our analysis to the glycoforms observed by the DDA LC-MS/MS.
Analysis of fucosylation of the plasma proteins in the context of liver cirrhosis
The change of fucosylation in liver cirrhosis was determined on 18 glycopeptides covering 19 NxS/T sequons (Table 1 and  ESM Table S1 ). We focus on the application of our DIA LC-MS/MS workflow to the comparative quantification of fucosylation because our prior work on isolated glycoproteins shows that fucosylation changes are an important characteristic of the development of liver cirrhosis [23, 28] . Our current results show that the quantitative changes of fucosylated glycoforms of peptides can be evaluated efficiently in a complex mixture (unfractionated digest of the MARS 14 retentate) in a multiplex format by the GP-SWATH workflow. We opted to use the MARS 14 retentate to minimize false positive identifications from the background of tryptic digest of the less abundant plasma proteins and to minimize potential impact of these peptides on ionization efficiency/accuracy of quantification. However, selectivity of the soft fragmentation of (Fig. 2) where few other peaks were detected besides the expected analytes.
We have previously reported that the differences in fucosylation are site-specific, depend on the branching of the glycans, and differ between core and outer arm structures [23] . In this paper we highlight the multiplex comparisons across different proteins and glycopeptides without glycopeptide enrichment. Our results confirm our previous observations [23, 28] and expand the analysis to glycopeptides of additional proteins (ESM Table S1 ). Specific examples of the fucosylation changes (ratios of quantifiable pairs of glycoforms with/out fucose) are presented in Figs. 3, 4 , and 5. Separately, we present data from two biological replicates (two pooled samples of cirrhosis and two control pooled samples, five individual plasma samples in each pool) analyzed each in triplicate, to demonstrate the reproducibility of the comparative quantification. The results shows that biological differences are typically higher than the technical variability of the measurements as seen, for example, on the A3G3F1 glycoforms of the VVLHPNYSQVDIGLIK peptide of haptog l o bi n ( F i (Fig. 3B) . Average glycopeptide ratios of all the replicate measurements across all quantifiable pairs of glycoforms are summarized in the ESM Table S1 .
Our results confirm that the changes in fucosylation are protein-and site-specific but we also observe some general trends. Fucosylation of the bi-antennary glycopeptides increases less than fucosylation of tri-/tetra-antennary glycoforms typically in cirrhosis. Only 4 of 12 biantennary glycopeptide-pairs and 9 of 13 tri-/tetra-antennary glycopeptide-pairs show greater than 1.5-fold increase in cirrhosis (ESM Table S1 ). These differences are clearly protein-and site-specific as the increase of the A2G2F1/ A2G2 ratio of the QQQHLFGSNVTDCSGNFCLFRSETK peptide of serotransferin in cirrhosis is 0.97 (Fig. 3B ), but the A2G2F1/A2G2 ratio of the CGLVPVLAENYNK peptide of the same protein increases 2.26-fold. The A2G2F1/ A 2 G 2 r a t i o o f f i b r i n o g e n p e p t i d e GTAGNALMDGASQLMGENR increases 7.28-fold (ESM Table S1 ). A typical trend is observed in the case of the Fig. 4 Increased branching of the VVLHPNYSQVDIGLIK Nglycopeptide of haptoglobin expressed as (A3G3F1+A3G3)/ (A2G2F1+A2G2) and (A4G4F1+A4G4)/(A2G2F1+ A2G2) ratios of its glycoforms. Data represent triplicate (mean ± standard deviation) technical repeats of the two cirrhosis (Cirr) and healthy control (Ctrl) samples. The (A4G4F1+A4G4)/ (A2G2F1+A2G2) ratio is magnified ten times for clarity of presentation Fig. 5 Analysis of the A2F/A2, A2G1F/A2G1, A2G2F/A2G2, and A2G1BF/A2G1B ratios of Nglycoforms of the tryptic peptide EEQYNSTFR of IgG1 documents constantly high fucosylation of this immune glycoprotein in control and cirrhosis samples. Triplicate (mean ± standard deviation) technical repeats of the two cirrhosis (Cirr) and control (Ctrl) samples each are presented A2G2F1/A2G2 ratio of the VVLHPNYSQVDIGLIK peptide of haptoglobin (0.95-fold increase), A3G3F1/A3G3 ratio (2.41-fold increase), and the A4G4F1/A4G4 ratio (8.80-fold increase, Fig. 3A ). In addition, multiply fucosylated glycoforms were observed to increase more than singly fucosylated glycoforms, though only a few of these low intensity analytes could be quantified. For example, the ratio of A3G3F2/A3G3 glycoforms of serotransferin peptide QQQHLFGSNVTDCSGNFCLFRSETK increases 4.14-fold while the A3G3F1/A3G3 ratio on the same peptide increases 2.33-fold (Fig. 3B ) and the ratio of A3G3F2/A3G3 g l y c o f o r m s o f a n t i t r y p s i n p e p t i d e ADTHDEILEGLNFNLTEIPEAQIHEGFQELLR increases 2.84-fold, while a 1.72-fold increase is observed in the A3G3F1/A3G3 ratio (ESM Table S1 ).
The increase in branching (tetra-antennary structures) reported previously [29] is also clearly detectable in our datasets. The ratio of the A4G4/A2G2 glycoforms of the VVLHPNYSQVDIGLIK peptide of haptoglobin increases 1.5-fold while the A3G3/A2G2 ratio increases 7.4-fold (Fig. 4) . It is interesting to note that, in general, immunoglobulins (IgG1-4, IgA, IgM) and immune system-derived proteins like complement C3 show minimal increases in fucosylation (ESM Table S1 ). The example of IgG1 shows that the bi-antennary glycoforms typical of this immunoglobulin (A2F, A2G1F, A2G2F, A2G1BF) are fucosylated to a high degree (>85 %) but the fucosylation does not further increase in cirrhosis, except for a 90.5→95.6 increase in the percentage of A2F (Fig. 5 ). This could be related to the high degree of fucosylation, dominant bi-antennary structures of IgG, or even specific glycan structures or topologies (such as core vs. outer arm fucosylation). We do not fully explore these possibilities here but we do observe that IgA glycoforms which have a low percentage of fucosylation do not show an increase either and fucosylation of the tri-antennary glycoforms of complement C3 also do not increase in cirrhosis. It is therefore likely that in general the immune cells do not produce glycoproteins with increased fucosylation in the context of cirrhosis. Further evaluation will be needed to make this observation definitive.
In this paper, we do not pursue resolution of the outer arm and core fucosylation by exoglycosidase digests as described previously [23, 25] . We can, however, distinguish these types of glycoforms from the soft fragmentation data at least to some degree. Core fucosylated bi-antennary glycopeptides (like the glycopeptides of IgG1) [26, 28] produce one dominant fucosylated Y-ion because the fucose of the glycan core remains intact under the soft CID conditions. Bi-antennary glycopeptides fucosylated on the outer arm produce two Yions of comparable intensity (with/without fucose) based on approximately equal fragmentation of both arms (like the glycopeptides of haptoglobin which carry negligible amount of core fucose) [30] . This pair of ions is specific to the outer arm fucosylation under soft CID conditions. Assignment of the proportions in case of mixed outer arm/core fucosylated glycopeptides, which co-elute under the reversed phase chromatographic conditions, needs further study using synthetic glycopeptide standards. Assignments of the glycoforms are further validated by additional ions including the complementary B-ions (e.g., the 512-Da ion in case of outer arm fucosylated structures).
Conclusion
Fragmentation of complex N-glycopeptides under soft CID conditions (energy approximately half of the CE typically used for the fragmentation of peptides) yields predictable Y-ions with minimal fragmentation of nonglycosylated peptides. This selective fragmentation allows efficient extraction of the high mass Y-ions for quantitative DIA assessment of glycopeptides in complex samples (without glycopeptide enrichment). Selectivity of the Yions and retention time alignment of multiple glycoforms of the same peptide improve specificity of the DIA LC-MS/MS quantification. Our results show that the GP-SWATH workflow allows quantitative comparison of 130 glycoforms of 28 glycopeptides covering 10 protein groups in a complex background (without glycopeptide enrichment) of similar quality as our previous quantification of enriched glycopeptides from digests of simple glycoproteins mixtures [23, 28] . The results confirm that fucosylation of liver-secreted glycoproteins increases in liver cirrhosis and shows that the increase in fucosylation depends on the degree of glycan branching and is proteinand site-specific. We expect that the soft fragmentation conditions will allow efficient and multiplex DIA comparisons of various glycoforms of proteins much needed for the quantitative assessment of protein glycosylation in various (patho)physiological processes.
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